We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nicotine Suppresses Appetite by Binding Receptors in the Hypothalamus

By HospiMedica International staff writers
Posted on 21 Jun 2011
A new study that identifies critical molecular and synaptic mechanisms involved in nicotine-induced decrease in appetite suggests it may be possible to develop drugs to help quitters stop gaining weight when they give up smoking.

Researchers at Yale School of Medicine (Yale; New Haven, CT, USA) and Baylor College of Medicine (Houston, TX, USA) using a combination of pharmacological, molecular genetics, electrophysiological, and feeding studies in mice, found that activation of hypothalamic α3β4 nicotinic acetylcholine receptors leads to activation of pro-opiomelanocortin (POMC) neurons. More...
The POMC neurons and the subsequent activation of melanocortin 4 receptors were found to be critical for nicotinic-induced decreases in food intake in mice.

The researchers also showed that when given nicotine, mice that did not have the POMC pathway did not lose weight, whereas those, whose POMC pathway was still intact, did lose weight. These particular receptors were not the same as those known to trigger tobacco craving in smokers; according to the researchers, this means it may be possible to effect appetite suppression without triggering the reward centers in the brain. In fact, a nicotine-like drug, cytisine, also had the same effect: it specifically activated the nicotinic receptors in the hypothalamus, leading to reduced food intake and body fat in the mouse model. The effect was very specific, since a drug that blocked cytisine from binding to the receptor stopped the reduction in food intake. The study was published in the June 10, 2011, issue of Science.

"We found that nicotine reduced eating and body fat through receptors implicated in nicotine aversion and withdrawal rather than reward and reinforcement," said senior author Marina Picciotto, MD, PhD, a professor of neurobiology and pharmacology at Yale. "Ultimately, we would like to help people maintain their body weight when they kick the habit and perhaps help nonsmokers who are struggling with obesity."

Nicotine is an alkaloid found in the nightshade family of plants that constitutes approximately 0.6% - 3.0% of the dry weight of tobacco, with biosynthesis taking place in the roots and accumulation occurring in the leaves. In low concentrations (an average cigarette yields about 1 mg of absorbed nicotine), the substance acts as a stimulant in mammals, and is the main factor responsible for the dependence-forming properties of tobacco smoking. Nicotine content in cigarettes has slowly increased over the years, and one study found that there was an average increase of 1.6% per year between the years of 1998 and 2005; this was found for all major market categories of cigarettes.

Related Links:

Yale School of Medicine



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.